+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Plasma Therapeutics Market 2024-2028 - Product Thumbnail Image

Plasma Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 147 Pages
  • Global
From
Plasma Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Plasma Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Critical Care Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Critical Care Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Plasma Therapy Market Report 2026 - Product Thumbnail Image

Plasma Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Convalescent Plasma Therapy Market Report 2026 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Loading Indicator